Article
Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapy
9 Apr 2022
Abstract excerpt
Immunotherapy has shown significant promise as a treatment for cancer, such as lung cancer and melanoma. However, only 10%–30% of the patients respond to treatment with immune checkpoint blockers (ICBs), underscoring the need for biomarkers to predict response to immunotherapy. Here, we developed DeepGeneX, a computational framework that uses advanced deep neural network modeling and feature elimination to reduce...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
